Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EMD Serono
With
Merck Serono International SA
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Greater than or equal to 18 years of age
Has relapsing-remitting MS
Are willing and able to comply with the protocol for the duration of the study
You may not be if
Has significant leukopenia/lymphopenia (white blood cell count less than (\<) 0.5 times the lower limit of normal)
Has elevated liver function tests (aspartate aminotransferase \[AST\], Alanine transaminase \[ALT\], or alkaline phosphatase greater than (\>) 2 times the upper limit of normal or total bilirubin \> 1.5 times the upper limit of normal)
Has an allergy to human serum albumin or mannitol
Had treatment with an investigational product or procedure within 3 months
Has the presence of systemic disease or abnormal laboratory findings that might interfere with subject safety, compliance or evaluation of the condition under study
Has concomitant use of Avonex®, Betaseron®, Copaxone®, or Novantrone®
Clareo Health | Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects
